Latest Healthcare Research Reports

Tag: enteric disease testing market size

  • Enteric Disease Testing Market Expected To Reach $6.61 Billion By 2030 As Growth Accelerates At 6.3% CAGR

    Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

    Enteric Disease Testing Market Forecast Highlighting Growth From $5.17 Billion To $6.61 Billion

    The market for enteric disease testing has experienced robust expansion lately, projected to increase from $4.86 billion in 2025 to $5.18 billion by 2026, showcasing a compound annual growth rate (CAGR) of 6.6%. This historical growth trajectory has been fueled by factors such as the occurrence of waterborne illnesses, heightened awareness regarding food safety, the proliferation of laboratory diagnostics, initiatives for public health surveillance, and the overall prevalence of infectious diseases.

    The market for enteric disease testing is poised for significant expansion, projecting a valuation of $6.62 billion by 2030 with a compound annual growth rate of 6.3%. This anticipated surge is fueled by several key factors, including the increasing integration of rapid testing methods, advancements in molecular diagnostics, proactive measures for outbreak containment, heightened public consciousness regarding sanitation, and broader accessibility to healthcare services. Emerging trends expected to shape this market during the forecast period encompass a rise in foodborne illnesses, a growing consumer preference for quick diagnostic solutions, the wider application of stool-based diagnostic techniques, an elevated emphasis on public health surveillance, and a concentrated effort on the timely detection of pathogens.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp

    Enteric Disease Testing Market Growth Drivers And Industry Catalysts

    Globally, a rise in instances of diarrhea and hemolytic uremic syndrome (HUS) is anticipated to fuel the expansion of the enteric disease testing market. The primary culprit behind many diarrheal illnesses is the ingestion of tainted food and water, while HUS, a condition impacting the blood and its vessels, disproportionately affects youngsters experiencing diarrhea and stands as a significant mortality factor among children under five. The growing prevalence of both diarrheal diseases and HUS necessitates the development of diagnostic tools, consequently boosting the demand for enteric disease testing solutions. Illustrating this, a report from the World Health Organization in March 2024 indicated that approximately 443,832 children under the age of five and an additional 50,851 aged five to nine succumb to diarrhea annually. Furthermore, the world grapples with an estimated 1.7 billion cases of childhood diarrhea each year, underscoring how the escalating occurrences of enteric conditions will propel the enteric disease testing market forward.

    Enteric Disease Testing Market Segmentation And Category Breakdown

    The enteric disease testing market covered in this report is segmented –

    1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types

    2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (Pcr), Immunoassay, Chromatography And Spectrometry, Other Technologies

    3) By Application: Hospitals, Research Centers, Clinics, Other Applications

    Subsegments:

    1) By Bacterial Enteric Disease: Salmonella, Escherichia Coli (E. Coli), Shigella, Campylobacter, Clostridium Difficile (C. Diff)

    2) By Parasitic Enteric Disease: Giardia Lamblia, Entamoeba Histolytica, Cryptosporidium, Trichinella Spiralis

    3) By Viral Enteric Disease: Norovirus, Rotavirus, Adenovirus, Astrovirus

    4) By Other Disease Types: Fungal Enteric Infections, Foodborne Illnesses, Antibiotic-Associated Diarrhea

    #Enteric Disease Testing Market Trends Influencing Long-Term Demand

    In the enteric disease testing sector, significant players are prioritizing the creation of sophisticated diagnostic instruments, such as laboratory equipment, to boost diagnostic precision and elevate patient care standards. These laboratory instruments represent specialized apparatus and machinery employed within scientific and medical facilities for conducting tests, examining specimens, and producing reliable data crucial for diagnoses. Such tools are indispensable for refining the exactness of diagnostic methods and advancing research across diverse areas, including the detection of enteric illnesses. As an illustration, during March of 2023, Jiangsu Bioperfectus Technologies Co., Ltd., a biotechnology firm situated in China, introduced innovative real-time PCR kits meticulously engineered for the identification of infectious agents causing gastrointestinal ailments. These kits boast superior sensitivity and specificity, facilitating the precise identification of minute quantities of genetic material within a range of sample types. Furthermore, they expedite analytical processes, substantially curtailing turnaround times and boosting productivity in both diagnostic and research settings.

    Enteric Disease Testing Market Competitive Analysis Of Major Industry Participants

    Major companies operating in the enteric disease testing market are Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Trinity Biotech plc., Abbott Laboratories, Fisher Scientific Inc., Alere Inc., 3M Company., Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.

    Access The Complete Enteric Disease Testing Market Report:

    https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

    Enteric Disease Testing Market Largest Region By Revenue And Market Share

    North Americawas the largest region in the enteric disease testing market in 2025. Europeis expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Enteric Disease Testing Market Expected To Reach $6.61 Billion By 2030 As Growth Accelerates At 6.3% CAGR

    Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

    Enteric Disease Testing Market Forecast Highlighting Growth From $5.17 Billion To $6.61 Billion

    The market for enteric disease testing has experienced robust expansion lately, projected to increase from $4.86 billion in 2025 to $5.18 billion by 2026, showcasing a compound annual growth rate (CAGR) of 6.6%. This historical growth trajectory has been fueled by factors such as the occurrence of waterborne illnesses, heightened awareness regarding food safety, the proliferation of laboratory diagnostics, initiatives for public health surveillance, and the overall prevalence of infectious diseases.

    The market for enteric disease testing is poised for significant expansion, projecting a valuation of $6.62 billion by 2030 with a compound annual growth rate of 6.3%. This anticipated surge is fueled by several key factors, including the increasing integration of rapid testing methods, advancements in molecular diagnostics, proactive measures for outbreak containment, heightened public consciousness regarding sanitation, and broader accessibility to healthcare services. Emerging trends expected to shape this market during the forecast period encompass a rise in foodborne illnesses, a growing consumer preference for quick diagnostic solutions, the wider application of stool-based diagnostic techniques, an elevated emphasis on public health surveillance, and a concentrated effort on the timely detection of pathogens.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp

    Enteric Disease Testing Market Growth Drivers And Industry Catalysts

    Globally, a rise in instances of diarrhea and hemolytic uremic syndrome (HUS) is anticipated to fuel the expansion of the enteric disease testing market. The primary culprit behind many diarrheal illnesses is the ingestion of tainted food and water, while HUS, a condition impacting the blood and its vessels, disproportionately affects youngsters experiencing diarrhea and stands as a significant mortality factor among children under five. The growing prevalence of both diarrheal diseases and HUS necessitates the development of diagnostic tools, consequently boosting the demand for enteric disease testing solutions. Illustrating this, a report from the World Health Organization in March 2024 indicated that approximately 443,832 children under the age of five and an additional 50,851 aged five to nine succumb to diarrhea annually. Furthermore, the world grapples with an estimated 1.7 billion cases of childhood diarrhea each year, underscoring how the escalating occurrences of enteric conditions will propel the enteric disease testing market forward.

    Enteric Disease Testing Market Segmentation And Category Breakdown

    The enteric disease testing market covered in this report is segmented –

    1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types

    2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (Pcr), Immunoassay, Chromatography And Spectrometry, Other Technologies

    3) By Application: Hospitals, Research Centers, Clinics, Other Applications

    Subsegments:

    1) By Bacterial Enteric Disease: Salmonella, Escherichia Coli (E. Coli), Shigella, Campylobacter, Clostridium Difficile (C. Diff)

    2) By Parasitic Enteric Disease: Giardia Lamblia, Entamoeba Histolytica, Cryptosporidium, Trichinella Spiralis

    3) By Viral Enteric Disease: Norovirus, Rotavirus, Adenovirus, Astrovirus

    4) By Other Disease Types: Fungal Enteric Infections, Foodborne Illnesses, Antibiotic-Associated Diarrhea

    #Enteric Disease Testing Market Trends Influencing Long-Term Demand

    In the enteric disease testing sector, significant players are prioritizing the creation of sophisticated diagnostic instruments, such as laboratory equipment, to boost diagnostic precision and elevate patient care standards. These laboratory instruments represent specialized apparatus and machinery employed within scientific and medical facilities for conducting tests, examining specimens, and producing reliable data crucial for diagnoses. Such tools are indispensable for refining the exactness of diagnostic methods and advancing research across diverse areas, including the detection of enteric illnesses. As an illustration, during March of 2023, Jiangsu Bioperfectus Technologies Co., Ltd., a biotechnology firm situated in China, introduced innovative real-time PCR kits meticulously engineered for the identification of infectious agents causing gastrointestinal ailments. These kits boast superior sensitivity and specificity, facilitating the precise identification of minute quantities of genetic material within a range of sample types. Furthermore, they expedite analytical processes, substantially curtailing turnaround times and boosting productivity in both diagnostic and research settings.

    Enteric Disease Testing Market Competitive Analysis Of Major Industry Participants

    Major companies operating in the enteric disease testing market are Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Trinity Biotech plc., Abbott Laboratories, Fisher Scientific Inc., Alere Inc., 3M Company., Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.

    Access The Complete Enteric Disease Testing Market Report:

    https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

    Enteric Disease Testing Market Largest Region By Revenue And Market Share

    North Americawas the largest region in the enteric disease testing market in 2025. Europeis expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Enteric Disease Testing Market Expected To Reach $6.61 Billion By 2030 As Growth Accelerates At 6.3% CAGR

    Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

    Enteric Disease Testing Market Forecast Highlighting Growth From $5.17 Billion To $6.61 Billion

    The market for enteric disease testing has experienced robust expansion lately, projected to increase from $4.86 billion in 2025 to $5.18 billion by 2026, showcasing a compound annual growth rate (CAGR) of 6.6%. This historical growth trajectory has been fueled by factors such as the occurrence of waterborne illnesses, heightened awareness regarding food safety, the proliferation of laboratory diagnostics, initiatives for public health surveillance, and the overall prevalence of infectious diseases.

    The market for enteric disease testing is poised for significant expansion, projecting a valuation of $6.62 billion by 2030 with a compound annual growth rate of 6.3%. This anticipated surge is fueled by several key factors, including the increasing integration of rapid testing methods, advancements in molecular diagnostics, proactive measures for outbreak containment, heightened public consciousness regarding sanitation, and broader accessibility to healthcare services. Emerging trends expected to shape this market during the forecast period encompass a rise in foodborne illnesses, a growing consumer preference for quick diagnostic solutions, the wider application of stool-based diagnostic techniques, an elevated emphasis on public health surveillance, and a concentrated effort on the timely detection of pathogens.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp

    Enteric Disease Testing Market Growth Drivers And Industry Catalysts

    Globally, a rise in instances of diarrhea and hemolytic uremic syndrome (HUS) is anticipated to fuel the expansion of the enteric disease testing market. The primary culprit behind many diarrheal illnesses is the ingestion of tainted food and water, while HUS, a condition impacting the blood and its vessels, disproportionately affects youngsters experiencing diarrhea and stands as a significant mortality factor among children under five. The growing prevalence of both diarrheal diseases and HUS necessitates the development of diagnostic tools, consequently boosting the demand for enteric disease testing solutions. Illustrating this, a report from the World Health Organization in March 2024 indicated that approximately 443,832 children under the age of five and an additional 50,851 aged five to nine succumb to diarrhea annually. Furthermore, the world grapples with an estimated 1.7 billion cases of childhood diarrhea each year, underscoring how the escalating occurrences of enteric conditions will propel the enteric disease testing market forward.

    Enteric Disease Testing Market Segmentation And Category Breakdown

    The enteric disease testing market covered in this report is segmented –

    1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types

    2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (Pcr), Immunoassay, Chromatography And Spectrometry, Other Technologies

    3) By Application: Hospitals, Research Centers, Clinics, Other Applications

    Subsegments:

    1) By Bacterial Enteric Disease: Salmonella, Escherichia Coli (E. Coli), Shigella, Campylobacter, Clostridium Difficile (C. Diff)

    2) By Parasitic Enteric Disease: Giardia Lamblia, Entamoeba Histolytica, Cryptosporidium, Trichinella Spiralis

    3) By Viral Enteric Disease: Norovirus, Rotavirus, Adenovirus, Astrovirus

    4) By Other Disease Types: Fungal Enteric Infections, Foodborne Illnesses, Antibiotic-Associated Diarrhea

    #Enteric Disease Testing Market Trends Influencing Long-Term Demand

    In the enteric disease testing sector, significant players are prioritizing the creation of sophisticated diagnostic instruments, such as laboratory equipment, to boost diagnostic precision and elevate patient care standards. These laboratory instruments represent specialized apparatus and machinery employed within scientific and medical facilities for conducting tests, examining specimens, and producing reliable data crucial for diagnoses. Such tools are indispensable for refining the exactness of diagnostic methods and advancing research across diverse areas, including the detection of enteric illnesses. As an illustration, during March of 2023, Jiangsu Bioperfectus Technologies Co., Ltd., a biotechnology firm situated in China, introduced innovative real-time PCR kits meticulously engineered for the identification of infectious agents causing gastrointestinal ailments. These kits boast superior sensitivity and specificity, facilitating the precise identification of minute quantities of genetic material within a range of sample types. Furthermore, they expedite analytical processes, substantially curtailing turnaround times and boosting productivity in both diagnostic and research settings.

    Enteric Disease Testing Market Competitive Analysis Of Major Industry Participants

    Major companies operating in the enteric disease testing market are Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Trinity Biotech plc., Abbott Laboratories, Fisher Scientific Inc., Alere Inc., 3M Company., Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.

    Access The Complete Enteric Disease Testing Market Report:

    https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

    Enteric Disease Testing Market Largest Region By Revenue And Market Share

    North Americawas the largest region in the enteric disease testing market in 2025. Europeis expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Enteric disease testing market forecast (2026–2030)

    Enteric disease testing market forecast (2026–2030)

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Changes In Market Value Are Expected For The Enteric Disease Testing Market Over The 2026–2030 Period?

    The enteric disease testing market size has demonstrated robust growth in recent years. It is anticipated to increase from $4.86 billion in 2025 to $5.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.6%. Historically, this expansion has stemmed from factors including waterborne disease outbreaks, rising food safety concerns, the advancement of laboratory diagnostics, the implementation of public health monitoring programs, and the prevalence of infectious diseases.

    The enteric disease testing market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $6.62 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.3%. This projected growth throughout the forecast period stems from factors such as the increased uptake of rapid tests, advancements in molecular diagnostics, initiatives for outbreak preparedness, heightened sanitation awareness, and the broadening of healthcare access. Key trends anticipated during this period encompass the growing occurrence of foodborne illnesses, a greater need for swift diagnostic tests, the broadening application of stool-based diagnostic techniques, an increase in public health surveillance testing, and an emphasis on identifying pathogens early.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

    What Significant Factors Are Influencing The Enteric Disease Testing Market Expansion?

    A projected expansion in the enteric disease testing market is anticipated, driven by the rising prevalence of diarrhea and hemolytic urea syndrome (HUS). Contaminated food and water consumption stands as the primary factor contributing to diarrheal disease incidents. Hemolytic urea syndrome (HUS), a condition impacting the blood and blood vessels, frequently occurs in children experiencing diarrhea. Among children under five, diarrheal disease and HUS represent significant causes of mortality. The growing number of diarrhea and hemolysis cases will necessitate testing options, thereby boosting the demand for enteric disease testing solutions. For example, data from March 2024, released by the World Health Organization, a national agency based in Switzerland, indicated that diarrhea accounts for approximately 443 832 deaths annually among children under 5, alongside another 50 851 deaths in children aged 5 to 9 years. Furthermore, nearly 1.7 billion cases of diarrheal disease affect children worldwide each year. Consequently, the escalating occurrences of enteric diseases will fuel the expansion of the enteric disease testing market.

    Which Segments Define The Enteric Disease Testing Market Segment Structure?

    The enteric disease testing market covered in this report is segmented –

    1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types

    2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (Pcr), Immunoassay, Chromatography And Spectrometry, Other Technologies

    3) By Application: Hospitals, Research Centers, Clinics, Other Applications

    Subsegments:

    1) By Bacterial Enteric Disease: Salmonella, Escherichia Coli (E. Coli), Shigella, Campylobacter, Clostridium Difficile (C. Diff)

    2) By Parasitic Enteric Disease: Giardia Lamblia, Entamoeba Histolytica, Cryptosporidium, Trichinella Spiralis

    3) By Viral Enteric Disease: Norovirus, Rotavirus, Adenovirus, Astrovirus

    4) By Other Disease Types: Fungal Enteric Infections, Foodborne Illnesses, Antibiotic-Associated Diarrhea

    What Trends Are Affecting The Direction Of The Enteric Disease Testing Market?

    Major companies in the enteric disease testing market are concentrating on developing advanced diagnostic solutions, such as laboratory tools, to improve diagnostic accuracy and patient outcomes. Laboratory tools are specialized instruments and equipment employed in scientific and medical laboratories to conduct tests, analyze samples, and generate precise data for diagnostics. These tools are crucial for boosting the precision of diagnostic procedures and advancing research in various sectors, including enteric disease testing. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co., Ltd., a China-based biotechnology company, released real-time PCR kits specifically created for the diagnosis of gastrointestinal infectious diseases. These kits offer high sensitivity and specificity, enabling the accurate identification of low amounts of nucleic acids in diverse samples. They also facilitate quick analysis, substantially decreasing processing times and boosting throughput in diagnostic and research applications.

    Who Are The Established Players Within The Enteric Disease Testing Market?

    Major companies operating in the enteric disease testing market are Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Trinity Biotech plc., Abbott Laboratories, Fisher Scientific Inc., Alere Inc., 3M Company., Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.

    Get The Full Enteric Disease Testing Market Report:

    https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

    Which Region Has The Greatest Market Share In The Enteric Disease Testing Market?

    North America was the largest region in the enteric disease testing market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Enteric Disease Testing Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

    Browse Through More Reports Similar to the Global Enteric Disease Testing Market 2026, By The Business Research Company

    Food Pathogen Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/food-pathogen-testing-global-market-report

    Gastrointestinal Pathogen Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

    Infectious Disease Diagnostics Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Enteric Disease Testing Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

    Global Enteric Disease Testing Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Valuation Is Forecasted For The Enteric Disease Testing Market By 2030 Starting From Its 2026 Size?

    The enteric disease testing market has shown robust expansion in recent years. It is anticipated to increase from $4.86 billion in 2025 to $5.18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.6%. This historical growth can be attributed to various elements including waterborne disease outbreaks, rising food safety concerns, the expansion of laboratory diagnostics, public health monitoring programs, and the overall burden of infectious diseases.

    The market for enteric disease testing is projected to experience substantial growth over the coming years. This market is forecast to reach a valuation of $6.62 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.3%. Key factors driving this expansion during the forecast period include the increasing adoption of rapid tests, advancements in molecular diagnostics, proactive outbreak preparedness initiatives, heightened sanitation awareness, and the broadening of healthcare access. Significant trends anticipated in the same period involve a growing occurrence of foodborne illnesses, an elevated demand for swift diagnostic tests, the wider application of stool-based diagnostic techniques, an increase in public health surveillance testing, and a concentrated effort on identifying pathogens early.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp

    What Drivers Are Shaping The Future Growth Of The Enteric Disease Testing Market?

    A rise in instances of diarrhea and hemolytic urea syndrome (HUS) is anticipated to fuel the expansion of the enteric disease testing market in the future. Primarily, diarrheal illnesses stem from ingesting tainted food and water. Hemolytic urea syndrome (HUS) is a condition impacting the blood and its vessels, frequently observed in children experiencing diarrhea. Both diarrheal disease and HUS represent significant contributors to mortality among children younger than five years old. The increasing instances of diarrhea and hemolysis will require diagnostic solutions, thereby elevating the need for enteric disease testing solutions. As an illustration, in March 2024, the World Health Organization, a national agency based in Switzerland, reported that approximately 443 832 children under 5 years old and an additional 50 851 children aged 5 to 9 years succumb to diarrhea annually. Furthermore, approximately 1.7 billion instances of childhood diarrheal disease occur worldwide each year. Consequently, the rising prevalence of enteric diseases is expected to stimulate expansion within the enteric disease testing market.

    Which Segment Categories Define The Enteric Disease Testing Market?

    The enteric disease testing market covered in this report is segmented –

    1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types

    2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (Pcr), Immunoassay, Chromatography And Spectrometry, Other Technologies

    3) By Application: Hospitals, Research Centers, Clinics, Other Applications

    Subsegments:

    1) By Bacterial Enteric Disease: Salmonella, Escherichia Coli (E. Coli), Shigella, Campylobacter, Clostridium Difficile (C. Diff)

    2) By Parasitic Enteric Disease: Giardia Lamblia, Entamoeba Histolytica, Cryptosporidium, Trichinella Spiralis

    3) By Viral Enteric Disease: Norovirus, Rotavirus, Adenovirus, Astrovirus

    4) By Other Disease Types: Fungal Enteric Infections, Foodborne Illnesses, Antibiotic-Associated Diarrhea

    How Are Trends Transforming The Enteric Disease Testing Market Landscape?

    Leading companies in the enteric disease testing market are concentrating on creating sophisticated diagnostic methods, including specialized laboratory tools, with the aim of boosting diagnostic precision and improving patient outcomes. Laboratory tools are precise instruments and equipment utilized in scientific and medical laboratories to conduct tests, analyze samples, and generate accurate data for diagnostic purposes. These tools are vital for enhancing the exactness of diagnostic procedures and supporting research in diverse areas, such as enteric disease testing. For example, in March 2023, Jiangsu Bioperfectus Technologies Co., Ltd., a biotechnology company based in China, unveiled real-time PCR kits tailored specifically for identifying gastrointestinal infectious diseases. These kits deliver high sensitivity and specificity, allowing for the precise detection of minute quantities of nucleic acids across various samples. They also enable swift analysis, considerably shortening processing times and boosting throughput in both diagnostic and research applications.

    Who Are The Top Companies Competing In The Enteric Disease Testing Market?

    Major companies operating in the enteric disease testing market are Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Trinity Biotech plc., Abbott Laboratories, Fisher Scientific Inc., Alere Inc., 3M Company., Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.

    Read the full enteric disease testing market report here:

    https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

    Which Geographic Regions Are Influencing Demand In The Enteric Disease Testing Market?

    North America was the largest region in the enteric disease testing market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Enteric Disease Testing Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=6118&type=smp

    Browse Through More Reports Similar to the Global Enteric Disease Testing Market 2026, By The Business Research Company

    Iliac Stent Global Market Report

    https://www.thebusinessresearchcompany.com/report/iliac-stent-global-market-report

    Intracranial Stents Global Market Report

    https://www.thebusinessresearchcompany.com/report/intracranial-stents-global-market-report

    Coronary Stents Global Market Report

    https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Enteric Disease Testing Market Insights Report: Opportunities and Drivers 2030

    Enteric Disease Testing Market Insights Report: Opportunities and Drivers 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the enteric disease testing market from 2026–2035 with trusted insights from The Business Research Company

    How much is the Enteric Disease Testing Market valued at in 2026, and what valuation is forecast for 2030?

    The enteric disease testing market has experienced significant expansion recently. Its valuation is projected to increase from $4.86 billion in 2025 to $5.18 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.6%. This historical growth has been driven by factors such as waterborne disease outbreaks, heightened food safety concerns, the broadening of laboratory diagnostics, the implementation of public health monitoring programs, and the overall burden of infectious diseases.

    The enteric disease testing market is projected to experience substantial expansion over the upcoming years. By 2030, its valuation is anticipated to reach $6.62 billion, driven by a compound annual growth rate (CAGR) of 6.3%. This anticipated growth during the forecast period is linked to factors such as the increasing adoption of rapid testing, advancements in molecular diagnostics, proactive measures for outbreak preparedness, heightened awareness of sanitation, and the broadening reach of healthcare services. Key trends expected during this period involve a rise in foodborne disease cases, a greater need for quick diagnostic tests, wider use of stool-based diagnostic techniques, an increase in public health surveillance testing, and an emphasis on identifying pathogens at an early stage.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp

    What Drivers Are Influencing The Growth Of The Enteric Disease Testing Market?

    The rising incidence of diarrhea and hemolytic urea syndrome (HUS) is projected to drive the expansion of the enteric disease testing market moving forward. Contaminated food and water are identified as the main contributors to diarrheal disease cases. Hemolytic urea syndrome (HUS) is a disorder affecting the blood and blood vessels, most commonly seen in children with diarrhea. Both diarrheal disease and HUS are leading causes of death among children under five. The increasing cases of diarrhea and hemolysis will require diagnostic solutions, consequently boosting the demand for enteric disease testing solutions. For example, in March 2024, the World Health Organization, a Switzerland-based national agency, reported that diarrhea causes the death of approximately 443 832 children under 5 and an additional 50 851 children aged 5 to 9 years annually. Furthermore, there are nearly 1.7 billion global cases of childhood diarrheal disease each year. Therefore, the growing occurrences of enteric diseases will stimulate the growth of the enteric disease testing market.

    How Is The Enteric Disease Testing Market Organized Into Various Segments?

    The enteric disease testing market covered in this report is segmented –

    1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types

    2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (Pcr), Immunoassay, Chromatography And Spectrometry, Other Technologies

    3) By Application: Hospitals, Research Centers, Clinics, Other Applications

    Subsegments:

    1) By Bacterial Enteric Disease: Salmonella, Escherichia Coli (E. Coli), Shigella, Campylobacter, Clostridium Difficile (C. Diff)

    2) By Parasitic Enteric Disease: Giardia Lamblia, Entamoeba Histolytica, Cryptosporidium, Trichinella Spiralis

    3) By Viral Enteric Disease: Norovirus, Rotavirus, Adenovirus, Astrovirus

    4) By Other Disease Types: Fungal Enteric Infections, Foodborne Illnesses, Antibiotic-Associated Diarrhea

    Which Trends Are Influencing The Development Of The Enteric Disease Testing Market?

    Leading firms operating within the enteric disease testing market are prioritizing the creation of sophisticated diagnostic methods, such as laboratory instruments, to bolster diagnostic precision and enhance patient results. Laboratory instruments refer to specialized apparatus and machinery utilized in scientific and medical settings for conducting examinations, analyzing specimens, and producing precise diagnostic data for diagnostics. These instruments are vital for improving the exactness of diagnostic procedures and supporting research in various areas, including enteric disease testing. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co., Ltd., a biotechnology enterprise based in China, introduced real-time PCR kits specifically engineered for diagnosing gastrointestinal infectious conditions. These kits offer superior sensitivity and specificity, enabling the accurate identification of minute quantities of nucleic acids across diverse samples. Furthermore, they facilitate quick analysis, significantly cutting down processing durations and boosting throughput in diagnostic and research applications.

    Who Are The Prominent Global Companies Shaping The Enteric Disease Testing Market Landscape?

    Major companies operating in the enteric disease testing market are Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Trinity Biotech plc., Abbott Laboratories, Fisher Scientific Inc., Alere Inc., 3M Company., Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

    Which Region Currently Holds The Largest Share Of The Enteric Disease Testing Market?

    North America was the largest region in the enteric disease testing market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Enteric Disease Testing Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=6118&type=smp

    Browse Through More Reports Similar to the Global Enteric Disease Testing Market 2026, By The Business Research Company

    Food Pathogen Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/food-pathogen-testing-global-market-report

    Gastrointestinal Pathogen Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

    Infectious Disease Diagnostics Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Enteric Disease Testing Market Revenue and CAGR Forecast Analysis 2025–2029

    Global Enteric Disease Testing Market Revenue and CAGR Forecast Analysis 2025–2029

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What Is The Current Size And Growth Outlook For The Enteric Disease Testing Market?

    The market size for enteric disease testing has seen a substantial boost in recent periods. The market’s expected progression is from $4.62 billion in 2024 to $4.86 billion in 2025, with a compound annual growth rate (CAGR) of 5.2%. The historic growth can be associated with concerns surrounding the safety of water and food, an increase in outbreaks and epidemics, the globalization of food supplies, a surge in infections related to travel, and regulatory standards.

    The market size for enteric disease testing is anticipated to experience a robust growth in the coming years. It’s expected to escalate to $6.24 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 6.5%. This growth during the forecasted period is due to factors such as the incorporation of telemedicine and remote monitoring, the impact of climate change, inter-sector cooperation, antimicrobial resistance, and newly emerging enteric pathogens. Some notable trends projected during the same period comprise molecular diagnostics, integration of digital health, the use of artificial intelligence and machine learning, the rise of syndromic testing, and the adoption of point-of-care testing.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp

    What Core Drivers Are Expected To Influence The Enteric Disease Testing Market?

    The rise in diarrhea and hemolytic urea syndrome (HUS) cases are anticipated to boost the expansion of the enteric disease testing market. The primary reason for the prevalence of diarrhea is the intake of contaminated food and water. Hemolytic urea syndrome (HUS), a disorder that impacts blood and blood vessels, is predominantly seen in children with diarrhea. Diarrhea and HUS stand as some of the prime reasons for mortality in children under five. The surge in diarrhea and hemolytic instances will require testing solutions, thereby elevating the need for enteric disease testing solutions. For example, data from the Centers for Disease Control and Prevention state that diarrhea is the second largest cause of death among children under 5 years, with 801 thousand deaths globally, contributing to one in every nine child deaths per year. Hence, the mounting occurrences of enteric diseases will push the progression of the enteric disease testing market.

    Which Segmentation Categories Are Highlighted In The Enteric Disease Testing Market Analysis?

    The enteric disease testingmarket covered in this report is segmented –

    1) By Disease Type: Bacterial Enteric Disease; Parasitic Enteric Disease; Viral Enteric Disease; Other Disease Types

    2) By Technology: Traditional; Rapid; Convenience-Based; Polymerase Chain Reaction (PCR); Immunoassay; Chromatography And Spectrometry; Other Technologies

    3) By Application: Hospitals; Research Centers; Clinics; Other Applications

    Subsegments:

    1) By Bacterial Enteric Disease: Salmonella; Escherichia coli (E. coli); Shigella; Campylobacter; Clostridium Difficile (C. diff)

    2) By Parasitic Enteric Disease: Giardia lamblia; Entamoeba histolytica; Cryptosporidium; Trichinella spiralis

    3) By Viral Enteric Disease: Norovirus; Rotavirus; Adenovirus; Astrovirus

    4) By Other Disease Types: Fungal Enteric Infections; Foodborne Illnesses; Antibiotic-Associated Diarrhea

    Which Market Trends Are Expected To Define The Future Of The Enteric Disease Testing Market?

    Many leading firms within the enteric disease testing industry are keying into the development of cutting-edge diagnostic solutions, which may include specific lab tools, to elevate diagnostic precision and enhance patient results. The application of lab tools – unique gadgets and technology utilized in clinical and scientific laboratories for conducting tests, evaluating samples, and creating robust data – is absolutely crucial for enriching the specificity of diagnostic operations and driving research in several sectors, among which is enteric disease testing. For example, Jiangsu Bioperfectus Technologies Co., Ltd, a biotech firm headquartered in China, introduced real-time PCR kits custom-made for diagnosing gastrointestinal infectious ailments in March 2023. These kits offer exceptional sensitivity and distinctness, thereby enabling exact detection of minimal levels of nucleic acids across different samples types. Additionally, they support fast exploratory processes that considerably minimize processing periods and boost the efficiency of diagnostic and research activities.

    Who Are The Dominant Players In The Enteric Disease Testing Market Today?

    Major companies operating in the enteric disease testing market include Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Trinity Biotech plc., Abbott Laboratories, Fisher Scientific Inc., Alere Inc., 3M Company., Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

    Which Regional Markets Are Emerging As Key Hubs For The Enteric Disease Testing Market?

    North America was the largest region in the enteric disease testing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=6118&type=smp

    Browse Through More Reports Similar to the Global Enteric Disease Testing Market 2025, By The Business Research Company

    Healthcare Analytical Testing Services Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/healthcare-analytical-testing-services-global-market-report

    Automotive Testing Inspection And Certification Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/automotive-testing-inspection-and-certification-global-market-report

    Cold Plasma Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Enteric Disease Testing Industry Forecast to Hit $6.24 Billion by 2029 With a Strong 6.5% CAGR

    Enteric Disease Testing Industry Forecast to Hit $6.24 Billion by 2029 With a Strong 6.5% CAGR

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    What Are The Growth Projections For The Enteric Disease Testing Market Size During 2025–2029?

    The enteric disease testing market has experienced substantial growth recently. It is projected to increase from $4.62 billion in 2024 to $4.86 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.2%. Historically, this expansion has been driven by several factors, including worries about water and food safety, an increase in outbreaks and epidemics, the worldwide expansion of food supply chains, a rise in infections associated with travel, and the establishment of regulatory guidelines.

    The enteric disease testing market is projected to experience robust expansion over the coming years. This market is anticipated to reach a value of $6.24 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this growth during the forecast period include the incorporation of telemedicine and remote monitoring, the impacts of climate change, increased cross-sector collaboration, the rise of antimicrobial resistance, and the emergence of new enteric pathogens. Key trends anticipated during the forecast period encompass molecular diagnostics, the integration of digital health solutions, advancements in AI and machine learning, the increased adoption of syndromic testing, and the expansion of point-of-care testing.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp

    What Are The Drivers Pushing New Developments In The Enteric Disease Testing Market?

    The rising instances of diarrhea and hemolytic uremic syndrome (HUS) are anticipated to propel the expansion of the enteric disease testing market in the future. The primary factor behind diarrheal disease cases is the ingestion of contaminated food and water. Hemolytic uremic syndrome (HUS), a condition affecting the blood and blood vessels, is frequently observed in children experiencing diarrhea. Both diarrheal disease and HUS are major contributors to fatalities in children under the age of five. The increasing occurrences of diarrhea and HUS will require diagnostic methods, thereby elevating the demand for enteric disease testing solutions. For example, the Centers for Disease Control and Prevention reports that diarrhea is the second leading cause of death for children under 5, accounting for 801 thousand deaths globally and one out of every nine child deaths each year. Therefore, the growing prevalence of enteric diseases will drive the growth of the enteric disease testing market.

    Which Key Segments Fueling The Enteric Disease Testing Market?

    The enteric disease testingmarket covered in this report is segmented –

    1) By Disease Type: Bacterial Enteric Disease; Parasitic Enteric Disease; Viral Enteric Disease; Other Disease Types

    2) By Technology: Traditional; Rapid; Convenience-Based; Polymerase Chain Reaction (PCR); Immunoassay; Chromatography And Spectrometry; Other Technologies

    3) By Application: Hospitals; Research Centers; Clinics; Other Applications

    Subsegments:

    1) By Bacterial Enteric Disease: Salmonella; Escherichia coli (E. coli); Shigella; Campylobacter; Clostridium Difficile (C. diff)

    2) By Parasitic Enteric Disease: Giardia lamblia; Entamoeba histolytica; Cryptosporidium; Trichinella spiralis

    3) By Viral Enteric Disease: Norovirus; Rotavirus; Adenovirus; Astrovirus

    4) By Other Disease Types: Fungal Enteric Infections; Foodborne Illnesses; Antibiotic-Associated Diarrhea

    Which Ongoing Trends Are Expected To Shape The Enteric Disease Testing Market Outlook?

    Leading companies operating within the enteric disease testing market are concentrating on developing advanced diagnostic solutions, such as specialized laboratory instruments, to improve diagnostic accuracy and patient outcomes. Laboratory instruments are distinct tools and equipment utilized in scientific and medical laboratories to conduct tests, analyze specimens, and generate precise data essential for diagnostics. These tools are vital for increasing the precision of diagnostic methods and aiding research in various fields, including enteric disease testing. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co., Ltd., a China-based biotechnology company, unveiled real-time PCR kits specifically created for the diagnosis of gastrointestinal infectious diseases. These kits deliver high sensitivity and specificity, allowing for the accurate detection of minute amounts of nucleic acids in diverse samples. They also enable swift analysis, considerably reducing processing times and boosting throughput in both diagnostic and research applications.

    Which Major Industry Participants Are Leading The Enteric Disease Testing Market Growth?

    Major companies operating in the enteric disease testing market include Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Trinity Biotech plc., Abbott Laboratories, Fisher Scientific Inc., Alere Inc., 3M Company., Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

    What Are The Key Regional Factors Influencing The Enteric Disease Testing Market Growth?

    North America was the largest region in the enteric disease testing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Request A Customized Version Of The Enteric Disease Testing Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=6118&type=smp

    Browse Through More Reports Similar to the Global Enteric Disease Testing Market 2025, By The Business Research Company

    Healthcare Analytical Testing Services Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/healthcare-analytical-testing-services-global-market-report

    Automotive Testing Inspection And Certification Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/automotive-testing-inspection-and-certification-global-market-report

    Cold Plasma Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Major Trends and Emerging Patterns in the Enteric Disease Testing Market: Advancements in Enteric Disease Testing: The Role of Laboratory Tools in Enhancing Diagnostic Accuracy

    Major Trends and Emerging Patterns in the Enteric Disease Testing Market: Advancements in Enteric Disease Testing: The Role of Laboratory Tools in Enhancing Diagnostic Accuracy

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What is the Projected CAGR for the Enteric Disease Testing Market Size from 2025 to 2034?

    In recent times, there has been a significant surge in the size of the enteric disease testing market. The market, which was worth $4.62 billion in 2024, is projected to climb to $4.86 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.2%. The historical period’s growth is primarily due to issues related to the safety of food and water, the rise in outbreaks and epidemics, the global accessibility of food supply, a higher number of infections linked to travel, and stringent regulatory standards.

    The market size of enteric disease testing is set to undergo significant expansion in the coming years, rising to a value of$6.24 billion by 2029, with a CAGR of 6.5%. Several factors responsible for this projected growth during the forecast period include the incorporation of telemedicine and remote monitoring, the impact of climate change, cross-industry collaboration, antimicrobial resistance and newly emerging enteric pathogens. Key trends anticipated during the forecast period consist of molecular diagnostics, digital health incorporation, the application of artificial intelligence and machine learning, syndromic testing adoption and point-of-care testing.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp

    What Are the Primary Drivers Supporting the Market Growth of the Enteric Disease Testing Market?

    The enteric disease testing market is predicted to grow due to a rise in the number of diarrhea and hemolytic urea syndrome (HUS) cases. The prevalent reason for cases of diarrhea disease is the intake of polluted food and water. The disorder, HUS, impacts blood and blood vessels and is predominantly observed in children with diarrhea. Diarrhea disease and HUS account for most deaths in children aged five or less. The surging instances of diarrhea and hemolytic demand testing solutions, thereby fuelling the need for enteric disease testing solutions. To illustrate, the Centers for Disease Control and Prevention reports that diarrhea is the second leading cause of death in children younger than 5, with 801 thousand deaths globally, representing one in every nine child deaths each year. Therefore, the rise in enteric diseases prevalence will fuel the expansion of the enteric disease testing market.

    Which Primary Segments of the Enteric Disease Testing Market Are Driving Growth and Industry Transformations?

    The enteric disease testingmarket covered in this report is segmented –

    1) By Disease Type: Bacterial Enteric Disease; Parasitic Enteric Disease; Viral Enteric Disease; Other Disease Types

    2) By Technology: Traditional; Rapid; Convenience-Based; Polymerase Chain Reaction (PCR); Immunoassay; Chromatography And Spectrometry; Other Technologies

    3) By Application: Hospitals; Research Centers; Clinics; Other Applications

    Subsegments:

    1) By Bacterial Enteric Disease: Salmonella; Escherichia coli (E. coli); Shigella; Campylobacter; Clostridium Difficile (C. diff)

    2) By Parasitic Enteric Disease: Giardia lamblia; Entamoeba histolytica; Cryptosporidium; Trichinella spiralis

    3) By Viral Enteric Disease: Norovirus; Rotavirus; Adenovirus; Astrovirus

    4) By Other Disease Types: Fungal Enteric Infections; Foodborne Illnesses; Antibiotic-Associated Diarrhea

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=6118&type=smp

    Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Enteric Disease Testing Market?# Market?

    North America was the largest region in the enteric disease testing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    What Are the Most Significant Market Trends in the Enteric Disease Testing Market?

    Leading firms in the enteric disease testing market are prioritizing the creation of innovative diagnostic solutions like laboratory tools, with the aim of increasing diagnostic precision and enhancing patient outcomes. Laboratory tools, including specialized instruments and equipment, play a critical role in medical and scientific laboratories by facilitating tests, sample analysis, and generating reliable data essential for diagnostics. These tools are pivotal in improving the accuracy of diagnostic procedures and promoting research in numerous areas, such as enteric disease testing. For example, Jiangsu Bioperfectus Technologies Co., Ltd., a Chinese biotech firm, introduced real-time PCR kits in March 2023. These kits are specifically made for diagnosing gastrointestinal infectious diseases and boast a high degree of sensitivity and specificity. This enables them to effectively detect small quantities of nucleic acids in different samples, and they also permit speedy analysis, dramatically cutting down processing times and enhancing throughput in both diagnostic and research capacities.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

    What Parameters Are Used to Define the Enteric Disease Testing Market?

    Enteric disease testing diagnoses enteric diseases such as food and water-borne diseases. Microorganisms such as viruses, bacteria, and parasites, cause enteric diseases that affect intestinal health. These pathogens can be contracted by contaminated food and drink and by coming into contact with the excrement of an infected animal or person. Abdominal cramping, vomiting, nausea, and anorexia are common symptoms of enteric disorders, which can cause the body to lose fluids and nutrients. Enteric disease testing involves tests and technologies such as diagnostic assays and rapid tests, testing of stool specimens, complete blood count (CBC) test, blood culture test, urine test, antibody test, and bone marrow test for the diagnosis of the enteric disease-causing agent.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6118

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Enteric Disease Testing Market Trends Report 2025 – For Business Development and Strategy Teams

    Enteric Disease Testing Market Trends Report 2025 – For Business Development and Strategy Teams

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Forecast for the Enteric Disease Testing Market Growth in 2025?

    In recent times, the enteric disease testing market has shown considerable growth. The market will escalate from a worth of $4.62 billion in 2024 to a worth of $4.87 billion in 2025, showcasing a compound annual growth rate (CAGR) of 5.4%. The surge in growth during the historic period can be credited to factors such as water and food safety apprehensions, a rise in disease outbreaks and epidemics, globalization of the food supply, augmented travel-related infections, and stringent regulatory standards.

    What Is the Forecast for the Enteric Disease Testing Market Size Through 2029?

    In the coming years, the enteric disease testing market is anticipated to experience robust expansion. The projection for its growth is a substantial increase to $6.29 billion by 2029, with a compound annual growth rate (CAGR) of 6.6%. Factors contributing to this surge during the forecast period include telemedicine integration, remote monitoring, effects of climate change, collaboration across sectors, resistance to antimicrobials, and new enteric pathogens. Forecast trends for the same period are centered on molecular diagnostics, the incorporation of digital health, AI and machine learning, syndromic testing adoption, and point-of-care testing.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp

    What are the Key Market Players in Enteric Disease Testing Market and How They’re Evolving?

    Major companies operating in the enteric disease testing market include Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Trinity Biotech plc., Abbott Laboratories, Fisher Scientific Inc., Alere Inc., 3M Company., Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.

    What Are the Primary Growth Drivers in the Enteric Disease Testing Market?

    The continual rise in instances of diarrhea and hemolytic urea syndrome (HUS) is anticipated to spur the development of the enteric disease testing market. The primary reason for instances of diarrhea is the ingestion of tainted food and water. Hemolytic urea syndrome, a disorder affecting blood and its vessels, is predominantly seen in children with diarrhea. These two diseases are key contributors to child mortality in those under five years old. The mounting cases of diarrhea and HUS necessitate testing options, therefore boosting the need for enteric disease testing. As an example, statistics from the Centers for Disease Control and Prevention unveil that diarrhea is the second leading cause of death in children under 5 worldwide, with 801 thousand fatalities – representing one in every nine child deaths each year. Therefore, the rising episodes of enteric illnesses are expected to fuel the expansion of the enteric disease testing market.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=6118&type=smp

    What Are the Leading Segments in the Global Enteric Disease Testing Industry?

    The enteric disease testing market covered in this report is segmented –

    1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types

    2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (PCR), Immunoassay, Chromatography And Spectrometry, Other Technologies

    3) By Application: Hospitals, Research Centers, Clinics, Other Applications

    Subsegments:

    1) By Bacterial Enteric Disease: Salmonella, Escherichia coli (E. coli), Shigella, Campylobacter, Clostridium Difficile (C. diff)

    2) By Parasitic Enteric Disease: Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Trichinella spiralis

    3) By Viral Enteric Disease: Norovirus, Rotavirus, Adenovirus, Astrovirus

    4) By Other Disease Types: Fungal Enteric Infections, Foodborne Illnesses, Antibiotic-Associated Diarrhea

    What Are the Key Market Trends in the Enteric Disease Testing Industry?

    Major players in the enteric disease testing market are investing in the creation of superior diagnostic tools, such as lab equipment, to elevate the dependability of diagnostics and enrich patient results. These lab tools are specific devices employed in scientific and medical labs to accomplish testing, scrutinize samples, and produce precise data needed for diagnostics. They play a key role in increasing the exactness of diagnostic processes, and advancing research in many areas, including enteric disease testing. For example, Jiangsu Bioperfectus Technologies Co., Ltd., a biotech firm based in China, introduced real-time PCR kits in March 2023 specifically made for diagnosing gastrointestinal infectious diseases. These kits offer great sensitivity and specificity, effectively identifying nucleic acids, even in low quantities, from diverse samples. Plus, they offer quick analysis, markedly cutting back on processing duration and enhancing throughput for both diagnostic and research use.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

    What Is the Regional Outlook for the Enteric Disease Testing Market?

    North America was the largest region in the enteric disease testing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6118

    This Report Delivers Insight On:

    1. How big is the enteric disease testing market, and how is it changing globally?

    2. Who are the major companies in the enteric disease testing market, and how are they performing?

    3. What are the key opportunities and risks in the enteric disease testing market right now?

    4. Which products or customer segments are growing the most in the enteric disease testing market?

    5. What factors are helping or slowing down the growth of the enteric disease testing market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model